The latest teaser pitch from Jeff Brown has gotten a lot of attention from Gumshoe readers… so let’s dig in and get some answers (and yes, some readers already posted their findings in our discussions area… so we’ll see if they got the right answer). The ad is all about a microcap biotech stock that […]
Articles
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. You can see all of his articles archived here. Enjoy!] CoLucid Pharmaceuticals, which recently moved from Durham, NC, to Cambridge, MA, plans an initial public offering. Recent news suggests the […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]
Antibiotic resistance is a big deal, as you undoubtedly already know — and resistant strains of various cooties are becoming more and more of a problem, particularly in hospital settings where they seem to spread like wildfire among the sick, infirm and open-wounded, but elsewhere as well. And the new wave of antibiotics is certainly […]
Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions.] If you get infected with CRE in your blood, your lungs, your urine, or your biliary system, what is your chance of […]
[ed. note: Dr. KSS writes about biotech stocks for the Irregulars. He has agreed to our trading restrictions, but he chooses his own topics and his words and thoughts are his own] According to new SEC filings, Cellceutix President, co-founder and Chief Scientific Officer Krishna Menon has recently settled what should probably be regarded as […]
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]
What’s the commonest reason for admission to hospital of people 65 and over? Mull that question, as it provides context. Think of people you know. At least one probably has this condition. It’s not diabetes. It’s not heart attacks. And it is not infectious. But it kills and lots of people have it. Part II […]
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Unfortunately bought AKAO and learned my lesson. Never again will I buy a biotech company developing an antibiotic. Ther...
$akao Entered at $1.38 share last week. Small position. Have been in and out of this one for awhile. Am concerned about ...
$AKAO > ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUT...
$AKAO np - Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant ...
$AKAO > Stock Quote Notification Stock information for Achaogen (NASDAQ:AKAO) for the week of 04/09/2018. Date Open...
$AKAO May 2 is the ADCOM meeting and June 25th is the deadline for FDA response. I've been holding through the decline f...
$AKAO - For those of us invested in Achaogen, the following might be of interest. Alley https://www.scribd.com/docum...
$AKAO Does anyone have an idea on why this continued to trade down after the NDA was filed? And I really do not unders...
$akao - Achaogen Appoints Blake Wise Chief Executive Officer - Dr. Kenneth Hillan to become President, R&D - - Suc...
$AKAO - 13th December Guggenheim Securities 5th Annual Boston Healthcare Conference http://investors.achaogen.com//even...
$AKAO - https://www.tipranks.com/email-alert/bfdaac4c-2d1f-4e76-984a-4d777d33774c...
A follow-up note on Achaogen. $AKAO. The company has announced plans to get into the pain space with a monoclonal ant...
$ AKAO Long Achaogen (AKAO $13.35) initiated buy with $17 target...
$AKAO H.C. Wainwright Starts Achaogen (AKAO) at Buy June 15, 2017 7:07 AM H.C. Wainwright initiates coverage o...
$AKAO: "Aegis Capital Reiterates Buy Rating and $39 PT on Achaogen (AKAO) Following 4Q Results; 'Next Step for Plazom...
$AKAO: -How much weight should one place on financial analyst opinions on stock recommendations? IMO, this provides th...
Wow!!! Achaogen (AKAO) PT Raised to $25 at William Blair William Blair analyst Y. Katherine Xu reiterated an Outpe...
A morning missive about Cempra ($CEMP). This is mainly for new Gummie Phil Kobi, and I am quite thrilled he joined us he...
New 'Signal' podcast at statnews on the battle--which we may be losing--against infectious diseases. SG favorite Acha...
Dr. KSS listed 29 companies that he rated A, A-, B+, B, or B-. Adding $ENUM and $CCXI, which are likely to have "A" or ...
Hi dave: You know, I had meant to do it last weekend and got waylaid: Aurinia $AUPH buy Achaogen $AKAO: hold vs...
I thought you guys would like a little refresher on Dr. KSS's holdings as of Feb 14, 2015. There may have been some addi...
AKAO -- Weekly Report 3/22/15 FRIDAY CLOSES …..4 Fridays Ago….$11.17 …..3 Fridays Ago….$10.32 ...
Seems like a pretty flimsy explanation for the $AKAO downgrade. I don't have access to the full report, but it would ...
Hey Gary, here are Doc's favorites up to date. Achaogen AKAO buy Achillion ACHN buy Actinium ATNM buy Agios AGIO hol...
To dispel any confusion, my current biotech holdings and sentiments on each: Achaogen AKAO buy Achillion ACHN...
Two recent 13g filings for Achaogen (AKAO) as well. http://www.nasdaq.com/symbol/akao/sec-filings Cheers,Glenn...
Alan KSS Post 352 on Ebola article: Also, to run my list for anyone interested: Long positions: sentiment Achaogen ...
Achaogen (AKAO) has a lot of job posts for hiring up in November especially in the clinical department.Hope a sign of go...
Hi all: My respect goes out to the retired and active service military members here, for doing something I would not ...
You are correct. We have discussed it. Don't remember positive or negative. I noticed last night the Achaogen AKAO wa...
I haven't touched on Achaogen (AKAO) in a while. This company has an antibiotic in late-stage clinical trials, co-sponso...
An antibiotics update for Irregulars.... I here reiterate a strong buy view on Achaogen (AKAO), which was up 8 per c...
7 pc up move in Achaogen (AKAO) albeit on light volume. Still, I'll take it. Again, this company has the trump card, the...